APTO
Closed
Aptose Biosciences Inc
2.03
+0.02 (+1.00%)
Last Update: 30 Apr 2025 16:30:00
Yesterday: 2.01
Day's Range: 2.03 - 2.06
Send
sign up or login to leave a comment!
When Written:
0.64
Aptose Biosciences Inc. is a clinical-stage biotechnology company that focuses on the discovery, research, and development of targeted therapies to treat cancer and other life-threatening diseases. The company's lead product candidate, APTO-253, is a small molecule that inhibits the expression of the MYC oncogene, which is frequently overexpressed in many types of cancer. Aptose is also developing other small molecule inhibitors of cancer targets, including BCL-2 and FLT3, and has a pipeline of preclinical programs in various stages of development. The company is headquartered in San Diego, California, and has a research and development facility in Toronto, Canada. Aptose Biosciences was founded in 1986 and is publicly traded on the NASDAQ stock exchange under the ticker symbol APTO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








